1Rutledge, AC & Adeli, K (2007) Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 65, S13–S23.
2Dekker, MJ, Su, Q, Baker, C, et al. (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299, E685–E694.
3Savage, DB, Petersen, KF & Shulman, GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87, 507–520.
4Weisberg, SP, McCann, D, Desai, M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
5Boden, G, She, P, Mozzoli, M, et al. (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54, 3458–3465.
6Solinas, G & Karin, M (2010) JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J 24, 2596–2611.
7Cai, D, Yuan, M, Frantz, DF, et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11, 183–190.
8Ghosh, S, May, MJ & Kopp, EB (1998) NF-κ B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225–260.
9Wellen, KE & Hotamisligil, GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.
10Tsigos, C, Kyrou, I, Chala, E, et al. (1999) Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48, 1332–1335.
11Uysal, KT, Wiesbrock, SM, Marino, MW, et al. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610–614.
12Kleemann, R & Bucala, R (2010) Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm 2010, 610479.
13Bucala, R (1996) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10, 1607–1613.
14Lue, H, Kleemann, R, Calandra, T, et al. (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4, 449–460.
15Calandra, T, Bernhagen, J, Mitchell, RA, et al. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179, 1895–1902.
16Fingerle-Rowson, GR & Bucala, R (2001) Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 79, 368–375.
17Flaster, H, Bernhagen, J, Calandra, T, et al. (2007) The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 21, 1267–1280.
18Wang, M (2005) The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab (Lond) 2, 3.
19Staab, CA & Maser, E (2010) 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 119, 56–72.
20Barnes, PJ (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120, 76–85.
21Spector, T (1978) Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0·5 to 50 microgram of protein. Anal Biochem 86, 142–146.
22Djordjevic, A, Milutinović, DV, Tanic, N, et al. (2012) Identification of suitable reference genes for gene expression studies in tissues from fructose-fed rats. Adv Sci Lett 5, 560–565.
23Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.
24Nagai, Y, Yonemitsu, S, Erion, DM, et al. (2009) The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 9, 252–264.
25London, E & Castonguay, TW (2011) High fructose diets increase 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity (Silver Spring) 19, 925–932.
26Rayssiguier, Y, Gueux, E, Nowacki, W, et al. (2006) High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res 19, 237–243.
27Wada, T, Kenmochi, H, Miyashita, Y, et al. (2010) Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology 151, 2040–2049.
28Roglans, N, Vila, L, Farre, M, et al. (2007) Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45, 778–788.
29Ye, J & Keller, JN (2010) Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) 2, 361–368.
30Bursać, B, Djordjevic, A, Vasiljević, A, et al. (2012) Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem (In the Press).
31Calandra, T, Bernhagen, J, Metz, CN, et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68–71.
32Fingerle-Rowson, G, Koch, P, Bikoff, R, et al. (2003) Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 162, 47–56.
33Atsumi, T, Cho, YR, Leng, L, et al. (2007) The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 179, 5399–5406.
34Verschuren, L, Kooistra, T, Bernhagen, J, et al. (2009) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105, 99–107.
35Tang, T, Zhang, J, Yin, J, et al. (2010) Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem 285, 4637–4644.
36Carlsen, H, Haugen, F, Zadelaar, S, et al. (2009) Diet-induced obesity increases NF-kappaB signaling in reporter mice. Genes Nutr 4, 215–222.
37Chung, MY, Park, HJ, Manautou, JE, et al. (2012) Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 23, 361–367.
38Toh, ML, Aeberli, D, Lacey, D, et al. (2006) Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 177, 4818–4825.
39Stojanovic, I, Cvjeticanin, T, Lazaroski, S, et al. (2009) Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 126, 74–83.
40Daun, JM & Cannon, JG (2000) Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am J Physiol Regul Integr Comp Physiol 279, R1043–R1049.
41De Bosscher, K, Schmitz, ML, Vanden Berghe, W, et al. (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94, 13504–13509.
42Kudrin, A, Scott, M, Martin, S, et al. (2006) Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem 281, 29641–29651.
43Skurk, T, Herder, C, Kraft, I, et al. (2005) Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146, 1006–1011.
44Dandona, P, Aljada, A, Ghanim, H, et al. (2004) Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89, 5043–5047.
45Saksida, T, Stosic-Grujicic, S, Timotijevic, G, et al. (2012) Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis. Immunol Cell Biol 90, 688–698.
46Toso, C, Emamaullee, JA, Merani, S, et al. (2008) The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 51, 1937–1946.
47Spruss, A, Kanuri, G, Wagnerberger, S, et al. (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50, 1094–1104.
48Haub, S, Kanuri, G, Volynets, V, et al. (2010) Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298, G335–G344.
49Hotamisligil, GS (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
50Akyildiz, M, Gunsar, F, Nart, D, et al. (2010) Macrophage migration inhibitory factor expression and MIF gene − 173 G/C polymorphism in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 22, 192–198.